Trident Texofab Peer Comparison

BSE: 540726

₹20.30

₹-0.99 (-4.65%)

As on 18-Sep-2026IST

Market cap

₹30 Cr

Revenue (TTM)

₹116 Cr

P/E Ratio

146.4

P/B Ratio

0.5

Div. Yield

0 %

Edit

	Trident Texofab	Arvind	Swan	Garware Technical	Raymond
Market cap (₹ Cr)	30	15,028	9,228	8,011	6,511
Revenue (₹ Cr)	116	9,798	4,172	1,644	2,293
Net Profit (₹ Cr)	0.21	422.82	207.16	209.82	65.57
Net Margin (%)	0.18	4.29	4.21	12.43	2.75
RoE (%)	2.08	11.13	2.99	16.61	1.09
Price to Earnings	146.35	36.29	41.27	38.13	175.60
Price-To-Book	0.54	3.27	1.23	6.12	2.27

Income Statement (₹ Cr)

	Trident Texofab	Arvind	Swan	Garware Technical	Raymond
Operating Revenue	116.09	9,797.83	4,171.76	1,643.93	2,293.42
Total Income	117.68	9,863.09	4,919.15	1,687.71	2,384.58
Total Expenditure	111.62	8,730.44	4,406.13	1,338.35	2,037.46
EBITDA	4.47	1,067.39	-234.37	305.58	255.96
Depreciation	1.58	314.45	124.37	36.37	151.20
EBIT	2.89	752.94	-358.74	269.21	104.76
Interest	2.75	178.02	93.43	13.73	85.35
Other Income	1.59	65.26	747.39	43.78	91.16
Exceptional Items	-1.13	-39.84	0.00	-13.90	-201.42
Profit before Tax	0.60	600.34	295.22	285.36	-90.85
Provision for Tax	0.39	177.52	88.06	75.54	-156.42
Profit after Tax	0.21	422.82	207.16	209.82	65.57

	Trident Texofab	Arvind	Swan	Garware Technical	Raymond
Shareholder's Funds	55.58	4,044.19	7,536.40	1,354.42	2,843.98
Minority Interest	0.00	-15.89	15.29	-0.07	-26.69
Non-Current Liabilities	18.37	801.89	1,781.20	89.04	511.99
Current Liabilities	37.21	3,893.11	2,877.08	435.28	1,108.31
Total Liabilities	100.58	8,032.10	13,603.50	1,756.62	7,716.31

	Trident Texofab	Arvind	Swan	Garware Technical	Raymond
Non-Current Assets	20.52	3,995.73	7,932.44	638.02	2,764.46
Current Assets	78.41	4,441.27	5,487.27	1,191.65	1,906.27
Total Assets	100.58	8,032.10	13,603.50	1,756.62	7,716.31
Total Debt*	26.50	1,375.96	2,823.49	61.42	676.81
Net Current Assets	41.20	548.16	2,610.20	756.37	797.96
Contingent Liabilities	1.05	46.83	1,262.43	8.91	98.95

	Trident Texofab	Arvind	Swan	Garware Technical	Raymond
Cash From Operating Activities	-13.72	762.88	-528.86	196.12	233.14
Cash Flow from Investing Activities	4.50	-503.53	1,345.52	10.29	-231.74
Cash from Financing Activities	12.23	-270.92	-559.76	-331.83	-103.79
Net Cash Inflow / Outflow	3.00	-11.57	256.89	-125.42	-102.39

	Trident Texofab	Arvind	Swan	Garware Technical	Raymond
ROCE (%)	11.43	13.98	16.64	24.74	2.32
ROE (%)	2.08	11.13	2.99	16.61	1.09
ROA (%)	0.20	4.99	1.51	11.54	1.05
EBIT Margin (%)	2.49	7.68	-8.60	16.38	4.57
Net Margin (%)	0.18	4.29	4.21	12.43	2.75
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Trident Texofab	Arvind	Swan	Garware Technical	Raymond
Revenue Growth (%)	-6.70	15.21	-16.72	4.64	13.45
EBIT Growth (%)	-24.42	21.12	44.41	-8.26	165.69
Net Profit Growth (%)	-92.66	11.39	-67.27	-11.79	-22.68
EPS Growth (%)	-66.82	19.25	-64.96	-55.89	-24.56
Book Value Growth (%)	165.16	6.76	16.94	0.62	-19.86

	Trident Texofab	Arvind	Swan	Garware Technical	Raymond
Price / Earnings	26.05	33.01	41.27	36.79	195.31
Price / Book Value	0.54	3.27	1.23	6.12	2.27
Dividend Yield (%)	0.00	0.81	0.05	1.10	0.00
EV/EBITDA	12.03	15.06	-42.51	24.97	26.65
Market Cap (₹ Cr)	237.01	8,252.18	13,476.92	8,572.11	9,340.35

	Trident Texofab	Arvind	Swan	Garware Technical	Raymond
Debt to Equity	0.24	0.07	0.19	0.01	0.16
Short term debt to equity ratio	0.34	0.26	0.11	0.05	0.09
Current Ratio	2.11	1.14	1.91	2.74	1.72
Quick Ratio	1.55	0.58	1.49	1.82	1.28
Interest Coverage	1.22	4.37	4.16	21.79	-0.06

	Trident Texofab	Arvind	Swan	Garware Technical	Raymond
Debtors to sales (%)	41.82	14.74	53.83	16.83	22.71
Asset Turnover	1.10	1.16	0.30	0.90	0.37
Receivable days	115.01	48.13	120.76	68.03	169.93
Inventory Days	43.85	88.33	70.31	61.82	368.71
Payable days	54.41	95.29	44.06	203.87	608.16
Cash Conversion Cycle	104.45	41.17	147.02	-74.01	-69.52

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.